The neuropathological hallmark of Alzheimer's disease (AD) is the co-occurrence of extracellular amyloid-β (Aβ) deposition and intraneuronal neurofibrillary changes composed of abnormal tau. Over the last decades, the concept emerged that neurofibrillary changes progress in a hierarchical manner from mesial temporal structures through the associative neocortex to primary sensory and motor fields, paralleling cognitive deterioration closer than Aβ. The observation that two patients (one cognitively normal, one with dementia) exhibited neurofibrillary changes closely overlapping as regards their entity and topographic distribution but differed for characteristics of Aβ deposition suggests that the latter may directly contribute in determining cognitive impairment in AD.
Divergent cognitive status with the same braak stage of neurofibrillary pathology : does the pattern of amyloid-β deposits make the difference? / E. Maderna, C. Cattaneo, F. Cacciatore, M. Catania, G. Di Fede, F. Tagliavini, G. Giaccone. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 43:2(2015), pp. 375-379. [10.3233/JAD-140540]
Divergent cognitive status with the same braak stage of neurofibrillary pathology : does the pattern of amyloid-β deposits make the difference?
C. CattaneoSecondo
;
2015
Abstract
The neuropathological hallmark of Alzheimer's disease (AD) is the co-occurrence of extracellular amyloid-β (Aβ) deposition and intraneuronal neurofibrillary changes composed of abnormal tau. Over the last decades, the concept emerged that neurofibrillary changes progress in a hierarchical manner from mesial temporal structures through the associative neocortex to primary sensory and motor fields, paralleling cognitive deterioration closer than Aβ. The observation that two patients (one cognitively normal, one with dementia) exhibited neurofibrillary changes closely overlapping as regards their entity and topographic distribution but differed for characteristics of Aβ deposition suggests that the latter may directly contribute in determining cognitive impairment in AD.File | Dimensione | Formato | |
---|---|---|---|
jad140540.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
392.36 kB
Formato
Adobe PDF
|
392.36 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.